Interestingly, K1 and BCPAP cells co-treated with Acrp30 and leptin displayed the same invasion capability of untreated cells indicating that Acrp30 and leptin display antagonizing effects on thyroid cancer cell invasion (Fig. 7). Here, ADIPOQ is linked to thyroid gland carcinoma.